Home » Topics » Regulatory » Patents

Patents
RSS

Actelion Pharmaceuticals patents new lipoxin receptor agonists

Feb. 23, 2015

Vichem Chemie Research discloses new FLT3 inhibitors

Feb. 23, 2015

CEPT inhibitors designed at Merck & Co.

Feb. 20, 2015

Pfizer presents RORC2 inhibitors

Feb. 20, 2015

New HIV protease inhibitors disclosed by Merck & Co.

Feb. 20, 2015

Metabolic Solutions Development divulges PPAR-sparing compounds

Feb. 20, 2015

Servier and Vernalis patent novel Bcl-2 inhibitors

Feb. 20, 2015

Novartis reports SMN expression enhancers

Feb. 20, 2015

Merck KGaA discloses new BTK inhibitors

Feb. 20, 2015

Institut Pasteur Korea and Qurient report anti-TB compounds

Feb. 20, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...